Boston Scientific Corp

BSX•NYSE•HEALTHCARE

$44.25+0.67 (+1.54%)

-6.2% 30D•Market closed•Prev $43.58

-$15.27-25.7%

1 month

-0.5%

price return

Year to date

-53.3%

price return

Recent earnings

4/4

quarters beat

Big funds

8

hold this stock

News tone

Bullish

50 articles, 7 days

Key stats

Jul 26

Market cap: $65.77B
P/E: 18.5x
Forward P/E: 13.2x
Beta: 0.58
Volume: 20.69M
52-week range: $42.20 - $109.50

Analysts

What do analysts expect?

Current

$44.25

Target

$72.43

+28.18 (+63.7%) possible upside12 months

Fundamentals

Business quality, value, and expectations at a glance.

Fundamentals

Is the business strong?

Fairly priced and profitable.

Revenue (TTM): $20.6B
Net income (TTM): $3.6B
Net margin: 17.3%
P/E: 18.51
Forward P/E: 13.19
Market cap: $65.8B

Valuation

P/S3.19
P/B2.54

Quality

Operating margin20.6%
ROE14.7%
ROA6.1%

Growth

Beta0.58

Earnings

Recent earnings versus expectations

Last 8 quarters

QuarterEPS resultNext day

Q1 '26beat +1.0%+1.3%

Q4 '25beat +2.6%+2.8%

Q3 '25beat +5.6%-1.4%

Q2 '25beat +2.7%Not available

Q1 '25beat +11.9%Not available

Q4 '24beat +6.1%Not available

Smart money

Filed positions and reported activity tied to this stock.

8 funds hold a position and insiders have been net buying.

Real smart money

Funds holding this stock

8 holders

Combined position$24.9B

P
PRIMECAP
Q1 2026 13F
$2.0B
position
DS
D.E. Shaw
Q1 2026 13F
$1.5B
position
TS
Two Sigma
Q1 2026 13F
$590.6M
position
B
BlackRock
Q1 2026 13F
$8.3B
position
FL
FMR LLC
Q1 2026 13F
$4.7B
position

Show all 8 holders

SS
State Street
Q1 2026 13F
$4.3B
position
JC
JPMorgan Chase
Q1 2026 13F
$2.1B
position
BO

Insiders

What insiders are doing

3 trades · 6 mo

Bought$554K

Buys (3)

HD
Habiger David C
Dir · Cluster · May 21
$251K
bought
LE
Ludwig Edward J
Dir · Cluster · May 21
$203K
bought

Checking federal contract awards

Coverage gaps for BSXNo recent market-voice mention

Technicals

Trend, range, and the price levels that matter.

Technicals

Price structure

This stock's price action is mixed.

Trend

Mixed

55 / 100

RSI 14

48balanced

20D volatility

32%annualized

52-week range

$44.25

$42.20$109.50

20D support

$42.20recent floor

20D resistance

$46.37recent ceiling

Returns

5D +0.5%20D +0.1%60D -24.3%

Price vs moving averages

SMA20 +0.6%SMA50 -6.7%SMA200 -40.5%

Volume pace

0.86xvs prior 20D

News

Recent coverage and its overall tone.

News

What the news says

50 articles · 7 days

Coverage is bullish

24 bullish · 21 neutral · 5 bearish

Tone of tracked coverage

BSX|Boston Scientific Corp|Price:43.770|Chg%:+0.190
BullishJul 24
BSX|Boston Scientific Corp|Price:43.590|Chg%:+0.620
BullishJul 24
Boston Scientific stock trades firm as cardiovascular revenue grows and TAVR momentum supports earni
NeutralJul 24
FDA names Dexcom as first participant in digital health pilot
Leans bullishJul 23
Boston Scientific Corp. stock outperforms competitors on strong trading day
Leans bullishJul 23
Avanos Medical (AVNS) Rebounds Sharply, Is The Stock Above Fair Value?
NeutralJul 23
Same Industry, Less Money: What Boston Scientific and ResMed Offers That Abbott Laboratories Does Not
NeutralJul 23
A 9-Day Winning Streak Has NOV Stock Up 10%
NeutralJul 23

Q3 '24beat +6.8%Not available

Q2 '24beat +6.9%Not available

Q1 '26beat +1.0%

$0.80 actualNext day +1.3%

Q4 '25beat +2.6%

$0.80 actualNext day +2.8%

Q3 '25beat +5.6%

$0.75 actualNext day -1.4%

Q2 '25beat +2.7%

$0.75 actualNext day not available

Q1 '25beat +11.9%

$0.75 actualNext day not available

Q4 '24beat +6.1%

$0.70 actualNext day not available

Q3 '24beat +6.8%

$0.63 actualNext day not available

Q2 '24beat +6.9%

$0.62 actualNext day not available

Bank of America

Q1 2026 13F

$1.4B

position

PC

Pegus Cheryl

Dir · Cluster · May 21

$100K

bought